Back to Search Start Over

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.

Authors :
Selak, Vanessa
Elley, C. Raina
Bullen, Chris
Crengle, Sue
Wadham, Angela
Rafter, Natasha
Parag, Varsha
Harwood, Matire
Doughty, Robert N.
Arroll, Bruce
Milne, Richard J.
Bramley, Dale
Bryant, Linda
Jackson, Rod
Rodgers, Anthony
Source :
BMJ: British Medical Journal. 6/7/2014, Vol. 348 Issue 7961, p11-11. 1p. 1 Chart.
Publication Year :
2014

Abstract

STUDY QUESTION Can one tablet containing aspirin, statin, and blood pressure lowering agents improve adherence and risk factor control compared with usual care of patients at high risk of cardiovascular disease in primary care? SUMMARY ANSWER Fixed dose combination treatment improved adherence to all the recommended drugs, but improvements in clinical risk factors were small and did not reach statistical significance. WHAT IS KNOWN AND WHAT THIS PAPER ADDS Two recent long term trials indicate large improvements in self reported adherence to the recommended drugs and modest improvements in risk factor control in high risk patients receiving fixed dose combination treatment. The main findings of this trial were consistent with those of the earlier trials, and acceptability for this treatment was high among general practitioners and patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17561833
Volume :
348
Issue :
7961
Database :
Academic Search Index
Journal :
BMJ: British Medical Journal
Publication Type :
Academic Journal
Accession number :
96380161
Full Text :
https://doi.org/10.1136/bmj.g3318